Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its stake in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 9.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,365,245 shares of the company's stock after purchasing an additional 278,466...